Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name list5-Acetyl-1H-Pyrazole-3-carboxylic acid

5-Acetyl-1H-Pyrazole-3-carboxylic acid

5-Acetyl-1H-Pyrazole-3-carboxylic acid Structural

What is 5-Acetyl-1H-Pyrazole-3-carboxylic acid?

The Uses of 5-Acetyl-1H-Pyrazole-3-carboxylic acid

5-acetyl-1H-pyrazole-3-carboxylic acid can be used in the industrialization of substances such as polyurethanes. Impurities in this chemical are removed through filtration before it is used for synthesis.

Definition

5-Acetyl-1H-pyrazole-3-carboxylic acid can be considered a valuable building block for other types of organic and medicinal chemistry transformations and is the essential starting material for the preparation of Darolutamide, which is chemically known as N-{(2S)-1-[3-(3-chloro-4- cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl}-5-(1-hydroxyethyl)-1H-pyrazole-3- 10 carboxamide. Orion Corporation and Bayer Health Care developed Darolutamide. It is an anti-androgen medication that is used for the treatment of prostate cancer in men. Recently, a safe and metal-free process using ethyl glycinate hydrochloride as the starting material has been developed to prepare 5-Acetyl-1H-Pyrazole-3-carboxylic acid[1-2].

Synthesis

5-Acetyl-1H-pyrazole-3-carboxylic acid is a chemical compound that is synthesized from hydrazine and acetyl chloride.
Potassium tert-butoxide (102 g) was added lot-wise to the pre-cooled mixture of 3,3-dimethoxybutane-2-one (100 g) in toluene (1000 ml) at 5-10°C and stirred for 45 minutes. Diethyl oxalate (132 g) was added to the mixture at 10-15°C and stirred for 4 hours. Filtered the solid. To the filtered solid water (3000 ml) was added and cooled to 5-10°C. Solution of Hydrazine monohydrochloride (51.8 g) was slowly added to the mixture at 5-10°C and stirred for 4 hrs. Dichloromethane (1000 ml) was added to the mixture at 5-10°C and stirred for 15 minutes. Allowed to heat the mixture to 25-30°C and stirred for 15 minutes. Filtered the mixture through hyflow. Organic layer was separated from the filtrate. Distilled-off the organic layer and co-distilled in n-heptane (50 ml). n-heptane (300 ml) was added to the mixture at 25-30°C. Heated the mixture at 45-50°C and stirred for 1 hrs. Allowed to cool the mixture to 25-30°C and stirred for 3 hours. Filtered the solid. THF (150 ml) was added to the obtained solid. aq. Sodium hydroxide solution was added to the mixture at 10-15°C. Heated the mixture to 55-60°C and stirred for 2 hrs. Allowed to cool the mixture to 25-30°C and stirred for 15 minutes. Separated the aqueous layer from organic layer. Water was added to the aqueous layer at 25-30°C. Cooled the mixture to 20-25°C. Treated the mixture with hydrochloric acid at 20-25°C. Allowed to heat the mixture to 25-30°C and stirred for 4 hours. Filtered the solid and dried. Tetrahydrofuran (300 ml) was added to the obtained solid at 25-30°C. Heated the mixture to 50-55°C and stirred for 60 minutes. Allowed to cool the mixture to 25-30°C and stirred for 3 hours. Filtered the solid and dried to get 5-Acetyl-1H-pyrazole-3-carboxylic acid, Yield: 63 gm Purity by HPLC: 99.93%.
synthesis of 5-Acetyl-1H-pyrazole-3-carboxylic acid

References

[1] László Poszávácz. "New, Scalable Process for the Preparation of 5-Acetyl-1 H -pyrazole-3-carboxylic Acid, a Key Intermediate of Darolutamide." Synthesis-Stuttgart 33 2 (2023): 2061–2069.
[2] Bence Szilágyi. "Safe and Efficient Continuous-Flow Synthesis and Batchwise Hydrolysis of Ethyl 5-Acetyl-1 H -pyrazole-3-carboxylate: A Key Synthon of Darolutamide." Synthesis-Stuttgart 212 1 (2022): 959–966.

Properties of 5-Acetyl-1H-Pyrazole-3-carboxylic acid

Melting point: 257-269 °C (decomp)(Solv: ethanol (64-17-5); benzene (71-43-2))
Boiling point: 479.2±30.0 °C(Predicted)
Density  1.467±0.06 g/cm3(Predicted)
storage temp.  2-8°C
pka 3.60±0.10(Predicted)
InChI InChI=1S/C6H6N2O3/c1-3(9)4-2-5(6(10)11)8-7-4/h2H,1H3,(H,7,8)(H,10,11)

Safety information for 5-Acetyl-1H-Pyrazole-3-carboxylic acid

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352:IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Computed Descriptors for 5-Acetyl-1H-Pyrazole-3-carboxylic acid

InChIKey HFBWRCZRDIVAMQ-UHFFFAOYSA-N
SMILES N1C(C(C)=O)=CC(C(O)=O)=N1

You may like

  • 1297537-45-1 5-ACETYL-1H-PYRAZOLE-3-CARBOXYLIC ACID 99%
    1297537-45-1 5-ACETYL-1H-PYRAZOLE-3-CARBOXYLIC ACID 99%
    1297537-45-1
    View Details
  • 51-80-9 Bis(dimethylamino)mathane 98%
    51-80-9 Bis(dimethylamino)mathane 98%
    51-80-9
    View Details
  • 42437-96-7 98%
    42437-96-7 98%
    42437-96-7
    View Details
  • 2-bromo-3-methoxy-6-methylpyridine 98%
    2-bromo-3-methoxy-6-methylpyridine 98%
    24207-22-5
    View Details
  • 591-31-1 98%
    591-31-1 98%
    591-31-1
    View Details
  • 21739-92-4 2-chloro-5-Bromo benzoic acid 98%
    21739-92-4 2-chloro-5-Bromo benzoic acid 98%
    21739-92-4
    View Details
  • R(+)2-(Di phenyl methyl)Pyrrolidine 22348-31-8 98%
    R(+)2-(Di phenyl methyl)Pyrrolidine 22348-31-8 98%
    22348-31-8
    View Details
  • 228410-90-0 5-bromo-4-methyl-3-nitropyridin-2-ol 98%
    228410-90-0 5-bromo-4-methyl-3-nitropyridin-2-ol 98%
    228410-90-0
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.